NGS

2-acetamido-2-deoxy-6-O-sulfo-beta-D-glucopyranose

Created:	1999-07-08
Last modified:	2020-07-17

Find Related PDB Entry
6 entries where NGS is found as a standalone ligand13 entries where NGS is found in a branched oligosaccharide

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	34
Chiral Atom Count	5
Bond Count	34
Aromatic Bond Count	0

2D diagram of NGS

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	2-acetamido-2-deoxy-6-O-sulfo-beta-D-glucopyranose
Synonyms	2-(acetylamino)-2-deoxy-6-O-sulfo-beta-D-glucopyranose; N-ACETYL-D-GLUCOSAMINE-6-SULFATE; N-acetyl-6-O-sulfo-beta-D-glucosamine; 2-acetamido-2-deoxy-6-O-sulfo-beta-D-glucose; 2-acetamido-2-deoxy-6-O-sulfo-D-glucose; 2-acetamido-2-deoxy-6-O-sulfo-glucose
Systematic Name (OpenEye OEToolkits)	[(2R,3S,4R,5R,6R)-5-acetamido-3,4,6-trihydroxy-oxan-2-yl]methyl hydrogen sulfate
Formula	C₈ H₁₅ N O₉ S
Molecular Weight	301.271
Type	D-SACCHARIDE, BETA LINKING

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=S(=O)(O)OCC1OC(O)C(NC(=O)C)C(O)C1O
SMILES	CACTVS	3.341	CC(=O)N[CH]1[CH](O)O[CH](CO[S](O)(=O)=O)[CH](O)[CH]1O
SMILES	OpenEye OEToolkits	1.5.0	CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)O)O
Canonical SMILES	CACTVS	3.341	CC(=O)N[C@H]1[C@H](O)O[C@H](CO[S](O)(=O)=O)[C@@H](O)[C@@H]1O
Canonical SMILES	OpenEye OEToolkits	1.5.0	CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O)COS(=O)(=O)O)O)O
InChI	InChI	1.03	InChI=1S/C8H15NO9S/c1-3(10)9-5-7(12)6(11)4(18-8(5)13)2-17-19(14,15)16/h4-8,11-13H,2H2,1H3,(H,9,10)(H,14,15,16)/t4-,5-,6-,7-,8-/m1/s1
InChIKey	InChI	1.03	WJFVEEAIYIOATH-FMDGEEDCSA-N

Related Resource References

Resource Name	Reference
PubChem	440235
ChEBI	CHEBI:28132

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.